Formulation and evaluation of Psyllium Husk-containing granules as a carrier to sustain the release of Water-Soluble drugs II
Mechanism of Drug Release
DOI:
https://doi.org/10.54361/ljmr.v14i1.05Keywords:
Release mechanism, granules, metformin, Psyllium husk, stearic acidAbstract
In previous work, the use of psyllium huskas the main component of sustained release preparations, was investigated. Granules of Metformin HCl containing different hydrocolloids namely; psyllium Husk and sodium carboxy-methyl cellulose (Na CMC), “System I”, and granules of sodium salicylate containing these hydrocolloids in addition to stearic acid, “System II’ were prepared. In vitro release studies in phosphate buffer solution (pH 6.8) clearly revealed the superiority of psyllium husk and Na CMCcombination in sustaining the release of both drugs. The introduction of stearic acid in formulations SC5 and SP5 have, significantly, slowed down the release of Sodium salicylate to 46% and 53%, respectively, after 7 hours. Mathematical modeling of the release data revealed that the release mechanism which describes the diffusion of both drugs from these systems is driven by a complex behavior such as swelling, matrix erosion as well as diffusion through the swollen matrix of most formulations. Evaluation of the drug release mechanism from these systems suggested that the release could be described by a complex mechanism, which may involve First-order kinetics, Higuchi diffusion controlled as well as Korsmeyer Peppas models
Downloads
References
Ghwel NS, Treki MS (2019) formulation and evaluation of psyllium husk-containing granules as a carrier to sustain the release of water-soluble drugs I: characterization and release studies, Europ J Biomed PharmSci. 6, 13: 108-117.
Higuchi T (1963)Mechanism of sustained-action medication: Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 52: 1145-1149.
Korsmeyer RW, Peppas NA(1981) In: Roseman TJ, Mansdorf SZ,editors. Macromolecular and modeling aspects of swelling controlled systems. New York: Marcel Dekker, pp. 77e90.
Peppas NA, Gurny R, Doelker E, Buri P (1980) Modelling of drug diffusion throughswellable systems. J Memb Sci. 7: 241-253.
Peppas NA,Korsmeyer RW(1987) Dynamically swelling hydrogels in controlledrelease applications, in hydrogels in medicines and pharmacy. In: Peppas NA,editor. Properties and Applications, vol. III. Boca Raton, FL: CRC Press Inc.; pp. 118-121.
Ritger PL, Peppas NA(1987) A simple equation for description of solute release I.Fickian and non-Fickian release from non-swellable devices in the form ofslabs, spheres, cylinders or Discs. J Contr Rel. 5:23-36.
Ritger PL, Peppas NA (1987) A simple equation for description of solute release I.Fickian and non-Fickian release from swellable devices. J Contr Rel.5: 37-42.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 Nesreen S Ghwel , Mahmud STreki (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Open Access Policy
Libyan journal of medical Research (LJMR).is an open journal, therefore there are no fees required for downloading any publication from the journal website by authors, readers, and institution.
The journal applies the license of CC BY (a Creative Commons Attribution 4.0 International license). This license allows authors to keep ownership f the copyright of their papers. But this license permits any user to download , print out, extract, reuse, archive, and distribute the article, so long as appropriate credit is given to the authors and the source of the work.
The license ensures that the article will be available as widely as possible and that the article can be included in any scientific archive.
Editorial Policy
The publication of an article in a peer reviewed journal is an essential model for Libyan journal of medical Research (LJMR). It is necessary to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the author, the journal editorial, the peer reviewer and the publisher.
Any manuscript or substantial parts of it, submitted to the journal must not be under consideration by any other journal. In general, the manuscript should not have already been published in any journal or other citable form, although it may have been deposited on a preprint server. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights, or the rights of a third party.
Authorship Policy
The manuscript authorship should be limited to those who have made a significant contribution and intellectual input to the research submitted to the journal, including design, performance, interpretation of the reported study, and writing the manuscript. All those who have made significant contributions should be listed as co-authors.
Others who have participated in certain substantive aspects of the manuscript but without intellectual input should only be recognized in the acknowledgements section of the manuscript. Also, one of the authors should be selected as the corresponding author to communicate with the journal and approve the final version of the manuscript for publication in the LJMR.
Peer-review Policy
- All the manuscripts submitted to LJMR will be subjected to the double-blinded peer-review process;
- The manuscript will be reviewed by two suitable experts in the respective subject area.
- Reports of all the reviewers will be considered while deciding on acceptance/revision or rejection of a manuscript.
- Editor-In-Chief will make the final decision, based on the reviewer’s comments.
- Editor-In-Chief can ask one or more advisory board members for their suggestions upon a manuscript, before making the final decision.
- Associate editor and review editors provide administrative support to maintain the integrity of the peer-review process.
- In case, authors challenge the editor’s negative decision with suitable arguments, the manuscript can be sent to one more reviewer and the final decision will be made based upon his recommendations.